NOVT - Rasio utang marang kapitalisasi buku Novanta Inc

Logo korporat perusahaan Novanta Inc. (NOVT)

Novanta Inc. (NOVT) generates revenue by creating precision systems for industry and healthcare, including motors for surgical robots and DNA analyzers. Demand for its optics is moderately subject to market cycles, with the indicator standing at 0.17. Serving as the primary valuation tool, this price chart visualizes the asset's dynamics. A high barrier to entry is maintained through an extensive patent portfolio for sensors and lasers.

Novanta Inc. - Utang-utang marang kapitalisasi buku NOVT (periode 04.07.2022 - 28.10.2026)
Barang unggulan Novanta Photonics

The dynamics of the total debt-to-net assets ratio reflect the sensitivity of the capital structure to operational flows, measuring the ability of equity to cover borrowed obligations. For Novanta Inc. (NOVT), with its mixed profile of medical and industrial assets, the company's balance sheet financial leverage on GURU.Markets serves as an indicator of resilience to recessions in the industrial sector, preventing the risk of business overheating.

Pesaing Novanta Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Haemonetics (HAE)|INSP - Rasio utang marang aset resik|PRCT: Utang-utang marang kapitalisasi buku|CNMD (CONMED Inc.) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Pulse Biosciences, Inc. PLSE|Rasio utang-utang marang kapitalisasi buku inmodemd.com|Picard Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Surmodics Inc SRDX|Utang marang nilai buku SENS (senseonics.com)|NPCE - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Tactile Systems Technology Inc. TCMD|SNWV - Utang marang modal buku|Outset Medical - Utang-utang marang kapitalisasi buku|Electromed (ELMD) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku LNSR|Utang marang nilai buku AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Utang marang nilai buku|Rasio utang marang aset resik BDMD (bairdmed.com)|EDAP TMS - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku